Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Routine hepatitis A childhood vaccination highly effective preventative measure

A project that offered free hepatitis A vaccination to children was highly effective in preventing the disease among recipients, according to an article in the latest issue of the Journal of the American Medical Association.

News image

fiogf49gjkf04

The project also appears to have decreased the incidence of hepatitis A among both children and adults and controlled the disease in a community with recurrent epidemics.

Francisco Averhoff, of the Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues conducted a community-based demonstration project from 12 January 1995 through 31 December 2000, in Butte County, California.

Butte County had recurrent outbreaks of hepatitis A between 1985 and 1994.

The 1994 rate was highest among children younger than the age of 15 (193.0 per 100,000 population).

For the Butte County project, vaccination was offered to children aged 2 to 12, during vaccination clinics conducted at most schools in the county in 1995. This was done on two occasions, 6 to 12 months apart.

Between 1996 and 2000, vaccine was distributed to community health care clinicians who vaccinated eligible children without charge.

Vaccine was also available at health department clinics, selected childcare centers, and other sites.

During the study period, 29,789 (66.2%) of an estimated 44,982 eligible children received at least one vaccine dose; 17,681 (39.3%) received a second dose.

"The number of hepatitis A cases among the entire county population declined 93.5% during the study period, from 57 cases in 1995 to 4 in 2000.

"This is the lowest number of cases reported in the county since hepatitis A surveillance began in 1966," the authors report.

"The 2000 incidence rate of 1.9 per 100,000 population was the lowest of any county in the state.

Number of hepatitis A cases declined 94% between 1995 and 2000.
Journal of the American Medical Association

"Of the 245 cases reported during the 6-year period, 40 (16.3%) occurred among children 17 years of age or younger, of which 16 (40%) occurred in 1995 and only 1 in 2000," they write.

"One of the 27 case patients eligible for vaccination had been vaccinated, having received the first dose 3 days before symptom onset."

"The estimated protective vaccine efficacy was 98%," the authors report.

No serious adverse events were reported among the vaccine recipients, supporting the safety of hepatitis A vaccination.

"This 6-year project demonstrated the feasibility and effectiveness of routine childhood hepatitis A vaccination and its impact on community-wide rates of disease," the authors assert.

"The decline appears to be sustained; only 2 cases were reported to the CDC during the first half of 2001," they report, citing unpublished CDC data.

"The Butte County experience suggests that, over time, routine vaccination of children can reduce overall disease rates in the community.

"This previews the potential impact of routine childhood hepatitis A vaccination, as recently recommended by the Advisory Committee on Immunization Practices for areas of the United States with consistently high hepatitis A infection rates," the authors conclude.

JAMA 2001; 286: 2968-73
19 December 2001

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us